alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 11,776–11,800 of 27,380 studies, newest first · page 472 of 1096.

April 2020 4

  1. 2020-04-01

    The consistent burden in published estimates of delirium occurrence in medical inpatients over four decades: a systematic review and meta-analysis study

    ✓ Peer-reviewed Caregiving Age and ageing

    Key finding: The incidence and prevalence of delirium in hospitals appears to be stable, though publication bias may have masked true changes. +4 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2020-04-01

    Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study

    ✓ Peer-reviewed Getting a diagnosis Brain : a journal of neurology

    Key finding: Moreover, biomarker plasma levels and rates of change over time of participants who developed Alzheimer's disease dementia during follow-up were compared with age and sex-matched dementia-free control subjects. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2020-04-01

    Association of Neighborhood-Level Disadvantage With Cerebral and Hippocampal Volume

    ✓ Peer-reviewed Prevention and risk JAMA neurology

    Key finding: For cognitively unimpaired individuals, living in the most disadvantaged neighborhoods was associated with significantly lower cerebral volumes, after controlling for maximal premorbid (total intracranial) volume. +3 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2020-04-01

    Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β

    ✓ Peer-reviewed Biomarkers JAMA neurology

    Key finding: While APOEε4 is associated with increased amyloid-β burden, its association with cerebral tau pathology has been controversial. +4 more findings

    Full summary, score breakdown and related studies → Original source

March 2020 21

  1. 2020-03-31

    Scalable diagnostic screening of mild cognitive impairment using AI dialogue agent

    ✓ Peer-reviewed Cognitive tests and assessment Scientific reports

    Key finding: To identify MCI status at the earliest possible point, recent studies have shown that linguistic markers such as word choice, utterance and sentence structures can potentially serve as preclinical behavioral markers.

    Full summary, score breakdown and related studies → Original source

  2. 2020-03-31

    Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging

    ✓ Peer-reviewed Biomarkers Alzheimer's research & therapy

    Key finding: Strong concordance between CSF biomarkers and Aβ-PET status was observed overall, including for cognitively normal participants, further strengthening the association between these markers of AD neuropathological burden for both developmental research studies and for use in clinical trials. +1 more finding

    Full summary, score breakdown and related studies → Original source

  3. 2020-03-31

    Neurodegenerative Diseases - Is Metabolic Deficiency the Root Cause?

    ✓ Peer-reviewed Inflammation and the immune system Frontiers in neuroscience

    Key finding: They are characterized by an inexorable loss of a specific type of neurons. +3 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2020-03-31

    A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease

    ✓ Peer-reviewed TREM2 and immune genetics Frontiers in immunology

    Key finding: Large-scale genome-wide association studies point out several genetic variants- TREM2, CD33, PILRA, CR1, MS4A, CLU, ABCA7, EPHA1 , and HLA-DRB5-HLA-DRB1 -potentially linked to neuroinflammation. +3 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2020-03-31

    Cognitive impairment in the U.S.: Lifetime risk, age at onset, and years impaired

    ✓ Peer-reviewed Disparities SSM - population health

    Key finding: Our results paint a multi-dimensional picture of cognitive health, presenting the first comprehensive analysis of the burden of cognitive impairment for the U.S. population age 50 and older. +2 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2020-03-31

    Mechanisms of cognitive dysfunction in CKD

    ✓ Peer-reviewed Prevention and risk Nature reviews. Nephrology

    Key finding: Patients with CKD are at an increased risk (compared with the general population) of both dementia and its prodrome, mild cognitive impairment (MCI), which are characterized by deficits in executive functions, memory and attention. +2 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2020-03-30

    The Genetics of Alzheimer's Disease in the Chinese Population

    ✓ Peer-reviewed Risk genes beyond APOE International journal of molecular sciences

    Key finding: In recent years, through the advancement of genome-wide association studies, second-generation gene sequencing technology, and their application in AD genetic research, more genetic loci associated with the risk for AD have been discovered, including KCNJ15, TREM2, and GCH1, which provides new ideas for the etiology and treatment of AD.

    Full summary, score breakdown and related studies → Original source

  8. 2020-03-30

    Implications of Medicare Advantage for Patients With Alzheimer Disease and Related Dementias

    ✓ Peer-reviewed Health systems and care delivery JAMA Network Open

    Key finding: fewer functional limitations in the MA population, perhaps explaining why those patients had fewer health care visits.

    Full summary, score breakdown and related studies → Original source

  9. 2020-03-30

    Health Care Utilization, Care Satisfaction, and Health Status for Medicare Advantage and Traditional Medicare Beneficiaries With and Without Alzheimer Disease and Related Dementias

    ✓ Peer-reviewed Health systems and care delivery JAMA Network Open

    Key finding: The sample included 47 100 Medicare beneficiaries (25 900 women [54.9%]; mean [SD] age, 72.2 [11.4] years). +4 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2020-03-27

    Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress

    ✓ Peer-reviewed Disease mechanisms Oxidative medicine and cellular longevity

    Key finding: Furthermore, protein misfolding and/or alterations during protein synthesis results in inactive or toxic proteins, which may overload the degradation mechanisms. +1 more finding

    Full summary, score breakdown and related studies → Original source

  11. 2020-03-26

    Relationship Between Exercise and Alzheimer's Disease: A Narrative Literature Review

    ✓ Peer-reviewed Hippocampus size on brain scans Frontiers in neuroscience

    Key finding: Most prospective studies have proven that physical inactivity is one of the most common preventable risk factors for developing AD and that higher physical activity levels are associated with a reduced risk of AD development. +1 more finding

    Full summary, score breakdown and related studies → Original source

  12. 2020-03-26

    Augmenting Computerized Cognitive Training With Vortioxetine for Age-Related Cognitive Decline: A Randomized Controlled Trial

    ✓ Peer-reviewed Prevention trials The American journal of psychiatry

    Key finding: Vortioxetine may be beneficial for age-related cognitive decline when combined with cognitive training. +3 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2020-03-26

    Machine learning prediction of incidence of Alzheimer's disease using large-scale administrative health data

    ✓ Peer-reviewed Digital health tools NPJ digital medicine

    Key finding: The results were similar when the entire (unbalanced) samples were used.

    Full summary, score breakdown and related studies → Original source

  14. 2020-03-25

    Neuropathological Mechanisms Associated with Pesticides in Alzheimer’s Disease

    ✓ Peer-reviewed Risk factors Toxics

    Key finding: Meanwhile, in vitro and animal models of AD have shed light on potential neuropathological mechanisms. +4 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2020-03-25

    Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline

    ✓ Peer-reviewed Treatments Neurology

    Key finding: There was no evidence that aspirin was effective in reducing risk of dementia, MCI, or cognitive decline. +1 more finding

    Full summary, score breakdown and related studies → Original source

  16. 2020-03-24

    Fecal Microbiota Transplantation in Neurological Disorders

    ✓ Peer-reviewed Disease mechanisms Frontiers in cellular and infection microbiology

    Key finding: Of 541 identified studies, 34 were included in the analysis. +4 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2020-03-24

    Motoric Cognitive Risk Syndrome: A Risk Factor for Cognitive Impairment and Dementia in Different Populations

    ✓ Peer-reviewed Clinical safety Annals of geriatric medicine and research

    Key finding: The mean prevalence of MCR worldwide, including in a Korean cohort, was around 10%. +4 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2020-03-24

    Prevalence, Risk Factors, and Complications of Oropharyngeal Dysphagia in Older Patients with Dementia

    ✓ Peer-reviewed Clinical safety Nutrients

    Key finding: These results show that OD is very prevalent among patients with dementia and is associated with impaired functionality, malnutrition, respiratory infections, and increased mortality.

    Full summary, score breakdown and related studies → Original source

  19. 2020-03-24

    Cognition Deficits in Parkinson's Disease: Mechanisms and Treatment

    ✓ Peer-reviewed Mild cognitive impairment Parkinson's disease

    Key finding: Of note, a patient with PD who suffers from cognitive impairment may harbour a statistically significantly higher risk of progressing toward dementia, which negatively affects their life expectancy and daily functioning and overall lowers the global quality of life.

    Full summary, score breakdown and related studies → Original source

  20. 2020-03-23

    Emerging risk of environmental factors: insight mechanisms of Alzheimer's diseases

    ✓ Peer-reviewed Risk factors Environmental science and pollution research international

    Key finding: Environmental risk factors might play an important role in decelerating or accelerating AD progression. +4 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2020-03-23

    The Pharmacological Activity, Biochemical Properties, and Pharmacokinetics of the Major Natural Polyphenolic Flavonoid: Quercetin

    ✓ Peer-reviewed Brain scans and imaging Foods (Basel, Switzerland)

    Key finding: Pharmacologically, quercetin has been examined against various microorganisms and parasites, including pathogenic bacteria, viruses, and Plasmodium , Babesia, and Theileria parasites. +4 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →